ArticleTherapeutic advances in musculoskeletal disease2021

Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis.

Sheng-Xiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.